Prior to joining Curate, Gaurav served as Head of BD for Precigen Inc. His background also includes key business development roles at Gilead Sciences, Shire Pharmaceuticals and Amgen, where he led various transactions across therapeutic areas (mostly oncology) and helped build large-pharma pipeline via sourcing external innovation. He earned his MBA from University of Michigan and his MS from Wayne State University, Michigan.
Speaking In
3:30 PM - 3:45 PM (PDT)
Wednesday, June 15

Curate Biosciences - Transformative Cell Processing for Next-Generation Therapies
At Curate…